Xeris Biopharma Holdings XERS
NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST

Xeris Biopharma Holdings (XERS) Common Stock Issued (2020 - 2026)

Updated

Xeris Biopharma Holdings (XERS) posted Common Stock Issued of $2.13 million for Q2 2026, up 18.4% from $1.8 million a year earlier but down 73.9% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Common Stock Issued (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Common Stock Issued at Xeris Biopharma Holdings was $25.92 million, up 258.6% year-over-year; for FY2025, it was $22.27 million.

  • Annual Common Stock Issued shows a five-year compound annual growth rate of -19.7% (FY2020 to FY2025).
  • In prior years, Xeris Biopharma Holdings' Common Stock Issued was $1.73 million in FY2024 (+198.3%), $581,000 in FY2023 (-98.1%), $30.84 million in FY2022 (+10.8%) and $27.84 million in FY2021 (-58.3%).
  • Quarterly Common Stock Issued has run from a low of $1,000 in Q3 2021 to a high of $30.01 million in Q1 2022 over five years.
  • On a year-over-year basis, Common Stock Issued has increased in each of the last three quarters, with growth averaging 265.1% over the last five quarters.
  • The strongest year-over-year quarter for Common Stock Issued in the past five years was Q1 2025, with growth of 959.0%; the weakest was Q4 2021, with a decline of 3.9%.
  • According to Business Quant data, Common Stock Issued for the three prior quarters was $8.18 million (Q1 2026), $1.27 million (Q4 2025) and $14.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 743.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 87.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Xeris Biopharma Holdings 2.89 Bn 2.41 Bn 94.80 Mn 675,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 675,000.00
Jun 30, 2026 2.13 Mn
Mar 31, 2026 8.18 Mn
Dec 31, 2025 1.27 Mn
Sep 30, 2025 14.33 Mn
Jun 30, 2025 1.80 Mn
Mar 31, 2025 4.86 Mn
Dec 31, 2024 564,000.00
Jun 30, 2024 710,000.00
Mar 31, 2024 459,000.00
Jun 30, 2023 581,000.00
Dec 31, 2022 318,000.00
Jun 30, 2022 510,000.00
Mar 31, 2022 30.01 Mn
Dec 31, 2021 294,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 514,000.00
Mar 31, 2021 27.03 Mn
Dec 31, 2020 306,000.00
API Access

Xeris Biopharma Holdings Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=XERS&period=max&api_key=YOUR_API_KEY